Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition
9 May 2026 – 14 May 2026 · Cape Town, South Africa
651-01-012 / 651-01-012 ISMRM Abstract

The Value of Histogram Analysis Based on APTw MRI for Predicting Muscle-Invasive Bladder Cancer: A Comparison with DWI

Primary: Body - Urogenital
Secondary: Analysis Methods - Radiomics
651-01-012 · Pelvic MRI: Bladder, Endometrium, and Rectum · Thursday, 14 May, 8:30 AM–10:06 AM · Power Pitch Theatre 1
651-01-012 · Pelvic MRI: Bladder, Endometrium, and Rectum · Thursday, 14 May, 8:30 AM–10:06 AM · Power Pitch Theatre 1
Keywords: Diffusion-Weighted Imaging Histogram Analysis Bladder cancer Muscle invasion Amide proton transfer-weighted imaging
Accepted
Shaoyu Huang 1, Li Tian1
1Department of Radiology, Sun yat-sen university cancer center, Guangzhou, China
Presenting Author: Shaoyu Huang

Synopsis

Motivation:
Goals:
Approach:
Results:
Full abstract & presentation

The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.

Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.

To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.

Log in

References

1. Witjes JA, Bruins HM, Cathomas R, Compérat EM, Cowan NC, Gakis G, et al. European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines. Eur Urol. 2021;79(1):82–104.
2. Babjuk M, Burger M, Capoun O, Cohen D, Compérat EM, Dominguez Escrig JL, et al. European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (Ta, T1, and Carcinoma in Situ). Eur Urol. 2022;81(1):75–94.
3. Chang SS, Bochner BH, Chou R, Dreicer R, Kamat AM, Lerner SP, et al. Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA/ASCO/ASTRO/SUO Guideline. J Urol. 2017;198(3):552–9.
4. Ro JY, Staerkel GA, Ayala AG. Cytologic and histologic features of superficial bladder cancer. Urol Clin North Am. 1992;19(3):435–53.
5. Wu B, Jia F, Li X, Li L, Wang K, Han D. Comparative Study of Amide Proton Transfer Imaging and Intravoxel Incoherent Motion Imaging for Predicting Histologic Grade of Hepatocellular Carcinoma. Front Oncol. 2020;10:562049.
6. Zhang H, Yong X, Ma X, Zhao J, Shen Z, Chen X, et al. Differentiation of low- and high-grade pediatric gliomas with amide proton transfer imaging: added value beyond quantitative relaxation times. Eur Radiol. 2021;31(12):9110–9.
7. Wang HJ, Cai Q, Huang YP, Li MQ, Wen ZH, Lin YY, et al. Amide Proton Transfer-weighted MRI in Predicting Histologic Grade of Bladder Cancer. Radiology. 2022;305(1):E59.
8. Su Y, Zhao H, Lyu Z, Xu P, Zhang Z, Zhang H, et al. Quantification of Intratumoral Heterogeneity Based on Habitat Analysis for Preoperative Assessment of Lymphovascular Invasion in Colorectal Cancer. Acad Radiol. 2025;32(8):4532–43.
9. Jiang S, Eberhart CG, Zhang Y, Heo HY, Wen Z, Blair L, et al. Amide proton transfer-weighted magnetic resonance image-guided stereotactic biopsy in patients with newly diagnosed gliomas. Eur J Cancer. 2017;83:9–18.
10. Fokkinga E, Hernandez-Tamames JA, Ianus A, Nilsson M, Tax CMW, Perez-Lopez R, et al. Advanced Diffusion-Weighted MRI for Cancer Microstructure Assessment in Body Imaging, and Its Relationship With Histology. J Magn Reson Imaging. 2024;60(4):1278–304.

Cite this abstract

http://echo.ismrm.org/p/ISMRM2026/651-01-012